xanomeline has been researched along with oxotremorine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abuh, YF; Dunbar, PG; Edgar, MA; El-Assadi, AA; Fang, Z; Huzl, JJ; Liu, Y; Messer, WS; Nagy, PI; Ngur, DO; Ojo, B; Periyasamy, S; Rho, T; Roknich, S; Sbeih, S; Zhang, H | 1 |
| Dei, S; Marconi, C; Pedretti, A; Romanelli, MN; Scapecchi, S; Vistoli, G | 1 |
| Bernhardt, G; Gmeiner, P; Hübner, H; Keller, M; Pegoli, A; She, X; Wifling, D | 1 |
| Butler, CR; Grimwood, S; Kablaoui, NM; Kozak, R; Lachapelle, EA; Lazzaro, JT; O'Connor, RE; Popiolek, M; Webb, D; Yang, Q; Zhang, L | 1 |
| Bernhardt, G; Carpenter, J; Chen, M; Gmeiner, P; Gruber, CG; Holliday, ND; Hübner, H; Keller, M; Pegoli, A; She, X; Wan, J; Wifling, D | 1 |
| Goodhead, LH; Mitchell, SN; Moss, S; Sharott, A | 1 |
| Carnicella, S; Oberling, P; Pain, L | 1 |
| Caine, SB; Fink-Jensen, A; Fulton, BS; Thomsen, M; Wess, J | 1 |
| Christopoulos, A; Felder, C; Leach, K; Loiacono, R; Sexton, P; Suratman, S | 1 |
| Hikichi, H; Maehara, S; Ohta, H | 1 |
| Dolejší, E; Doležal, V; El-Fakahany, EE; Jakubík, J; Randáková, A; Rudajev, V; Zimčík, P | 1 |
| Clarke, S; Reed, H; Sher, E; Zwart, R | 1 |
12 other study(ies) available for xanomeline and oxotremorine
| Article | Year |
|---|---|
Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Topics: Animals; Arecoline; Brain; Carbachol; Cell Line; Models, Molecular; Muscarinic Agonists; Phosphatidylinositols; Pyrimidines; Quinuclidinyl Benzilate; Rats; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; Structure-Activity Relationship | 1997 |
Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding.
Topics: Binding Sites; Computer Simulation; Humans; Ligands; Muscarinic Agonists; Protein Binding; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M5; Receptors, Muscarinic | 2008 |
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M
Topics: Benzodiazepinones; Binding Sites; Molecular Dynamics Simulation; Muscarinic Antagonists; Radioisotopes; Receptor, Muscarinic M2 | 2017 |
Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres.
Topics: | 2019 |
Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M
Topics: Animals; CHO Cells; Cholinergic Agents; Cricetulus; Fluorescent Dyes; Muscarinic Antagonists; Phthalimides; Protein Structure, Secondary; Quaternary Ammonium Compounds; Receptor, Muscarinic M2 | 2020 |
Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
Topics: Animals; Atropine; Bicuculline; Bridged-Ring Compounds; Carbachol; Cholinergic Agonists; Diamines; Dopamine; Hippocampus; Male; Microdialysis; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nucleus Accumbens; Oxotremorine; Pilocarpine; Pyridines; Rats; Receptors, Muscarinic; Spiro Compounds; Thiadiazoles; Tropanes | 2003 |
Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect.
Topics: Animals; Atropine; Conditioning, Classical; Fear; Male; Memory; Muscarinic Antagonists; Nicotine; Nicotinic Antagonists; Oxotremorine; Parasympathetic Fibers, Postganglionic; Pilocarpine; Psychopharmacology; Pyridines; Rats; Rats, Sprague-Dawley; Thiadiazoles | 2005 |
Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Female; Haloperidol; Male; Mice; Mice, Knockout; Muscarinic Agonists; Muscarinic Antagonists; Oxotremorine; Pyridines; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Reflex, Startle; Scopolamine; Thiadiazoles | 2010 |
Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor.
Topics: Acetylcholine; Allosteric Regulation; Allosteric Site; Animals; Cell Line; CHO Cells; Cricetinae; Cricetulus; Glycogen Synthase Kinase 3; Humans; Ligands; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Probe Techniques; Nicotinic Acids; Oxotremorine; Protein Binding; Pyridines; Receptor, Muscarinic M4; Species Specificity; Thiadiazoles; Thiophenes | 2011 |
Behavioral effects of N-desmethylclozapine on locomotor activity and sensorimotor gating function in mice-Possible involvement of muscarinic receptors.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Mice; Motor Activity; Muscarinic Agonists; Neural Inhibition; Oxotremorine; Psychophysics; Pyridines; Receptors, Muscarinic; Scopolamine; Sensory Gating; Thiadiazoles | 2011 |
Classical and atypical agonists activate M1 muscarinic acetylcholine receptors through common mechanisms.
Topics: Animals; Binding Sites; Calcium; Carbachol; Cell Membrane; CHO Cells; Cricetinae; Cricetulus; Inositol Phosphates; Models, Molecular; Muscarinic Agonists; Mutation; Oxotremorine; Pyridines; Receptor, Muscarinic M1; Receptors, G-Protein-Coupled; Thiadiazoles | 2015 |
A novel muscarinic receptor-independent mechanism of KCNQ2/3 potassium channel blockade by Oxotremorine-M.
Topics: Animals; Humans; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Oxotremorine; Potassium Channel Blockers; Pyridines; Receptor, Muscarinic M1; Thiadiazoles; Xenopus | 2016 |